Saturday 17 October 2026
Export SCL’s income statement to Excel — free account
Stepan Company
SCL Basic Materials Specialty Chemicals
Stepan Company’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.96% from fiscal 2024. In the quarter to June 2026, revenue grew 15.0%, EPS grew 100.0%, free cash flow fell 4.42% and total debt fell 1.62%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
62.03
0.16
+0.26%
Follow SCL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 23.10 | 24.09 |
+8 more quarters Free account |
P/S ratio |
0.52 | 0.49 | 0.46 | 0.47 | |
P/FCF ratio |
19.20 | 17.06 | 19.62 | 30.88 | |
P/Operating CF |
152.54 | 67.55 | 18.06 | 15.64 | |
P/B ratio |
1.05 | 0.96 | 0.87 | 0.88 | |
Price to Tangible BV |
1.18 | 1.08 | 0.97 | 0.99 | |
EV/Sales |
0.74 | 0.71 | 0.68 | 0.71 | |
EV/EBITDA |
12.13 | 12.70 | 7.71 | 8.24 | |
EV/Operating CF |
11.67 | 10.48 | 10.67 | 10.42 | |
EV/FCF |
27.24 | 24.67 | 28.56 | 46.07 | |
Quick Ratio |
0.72 | 0.80 | 0.78 | 0.78 | |
Current Ratio |
1.15 | 1.26 | 1.29 | 1.30 | |
Net Debt/EBITDA |
7.83 | (30.64) | 11.43 | 9.84 | |
Debt/Assets |
27.06% | 27.93% | 26.58% | 26.95% | |
Debt/Equity |
0.53 | 0.55 | 0.50 | 0.53 | |
Asset Turnover |
1.01 | 0.99 | 1.00 | 0.95 | |
Operating CF/Net income |
0.37 | (0.41) | 11.99 | 6.44 | |
Capex/Depreciation |
(0.76) | (0.94) | (0.25) | (0.90) | |
Interest Coverage |
6.55 | (9.90) | 1.85 | 3.20 | |
Research and Development Expense of Revenue |
2.51% | 2.48% | 2.84% | 2.41% | |
Selling, General and Administrative Expense of Revenue |
5.92% | 5.63% | 6.31% | 5.93% | |
Intangible Assets out of Total Assets |
0.05 | 0.06 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
0.31% | 0.25% | 0.28% | 0.24% | |
Graham Net Nets |
(0.16) | (0.20) | (0.24) | (0.24) | |
Graham Number |
0.00 | 0.00 | 50.09 | 49.28 | |
Earnings Yield |
(0.22%) | (1.24%) | 4.33% | 4.15% | |
Free Cash Flow Yield |
5.21% | 5.86% | 5.10% | 3.24% | |
Revenue per Share |
29.88 | 26.41 | 24.22 | 25.80 | |
Operating CF per Share |
0.37 | 0.74 | 2.62 | 3.05 | |
Capex per Share |
(1.02) | (1.35) | (0.35) | (1.29) | |
Free Cash Flow per Share |
(0.66) | (0.61) | 2.27 | 1.76 | |
Cash per Share |
4.97 | 6.15 | 5.80 | 5.18 | |
Shareholders Equity per Share |
52.93 | 52.12 | 54.39 | 54.50 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
52.93 | 52.12 | 54.39 | 54.50 | |
Free Cash Flow |
(15.04) | (13.95) | 51.96 | 40.21 | |
Working Capital |
127.77 | 185.79 | 192.47 | 211.25 | |
Capital Expenditures |
(23.41) | (30.89) | (8.03) | (29.55) | |
Net Current Asset Value |
(205.86) | (234.07) | (254.73) | (264.91) | |
EV/EBIT |
91.00 | 2,591.03 | 20.08 | 21.50 | |
Capex to Sales |
0.03 | 0.05 | 0.01 | 0.05 | |
Price to Operating Income |
64.16 | 1,790.77 | 13.79 | 14.41 | |
| Other line items | |||||
Average Receivables |
467.25 | 435.09 | 387.99 | 435.14 | |
Average Payables |
301.71 | 291.92 | 260.26 | 273.22 | |
Average Inventory |
326.97 | 299.17 | 293.77 | 310.49 | |
Average Assets |
2,404.40 | 2,361.51 | 2,331.18 | 2,423.04 | |
Average Common Equity |
1,226.88 | 1,196.78 | 1,206.97 | 1,233.07 |
Columns are period end dates